Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era-Reference-Cited by-同舟云学术

Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era

Published:2018-06-18 Issue:6 Volume:13 Page:e0199174
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zuckerman Autumn^ORCID,Douglas Andrew,Nwosu Sam,Choi Leena,Chastain Cody

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Committee on a National Strategy for the Elimination of Hepatitis B and C Board on Population Health and Public Health Practice Health and Medicine Division National Academies of Sciences E, and Medicine Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington (DC): National Academies Press (US); 2016.

2. Towards ending viral hepatitis,2016

3. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis;BR Yehia;PLoS One,2014

4. Barriers to Treatment Access for Chronic Hepatitis C Virus Infection: A Case Series;AJ Millman;Top Antivir Med,2017

5. Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance;V, 3rd Lo Re;Clin Gastroenterol Hepatol,2016

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post‐Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living With HIV With HCV Antibody Positivity in the Asia‐Pacific Region;Journal of Viral Hepatitis;2024-08-08

2. Hepatitis C-related knowledge and attitude among adults on probation in a large US city;Health & Justice;2024-07-11

3. Telemonitoring of the Continuum of Care of Hepatitis C During the COVID-19 Pandemic in Brazil;Telemedicine and e-Health;2023-11-01

4. Adapting a Data to Care Approach for HIV to Promote HCV Cure for Persons with HIV/HCV Co-infection;2023-10-27

5. Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study;Liver International;2023-09-17